Neonatal Neurobehavior, Medical Risk, and 2-year Developmental Outcomes in Infants Born Gestation
Elizabeth C. McGowan, Barry M. Lester(Brown University), Howard W. Kilbride(Children's Mercy Hospital), Marie Camerota(Providence College), Steven L. Pastyrnak(Spectrum Health), Lynne M. Smith(UCLA Medical Center), Michael O’Shea, Lynne M. Dansereau(Providence College), Sheri A. DellaGrotta(Providence College), Brian S. Carter(Carter Observatory), Jennifer Helderman(Atrium Health Wake Forest Baptist), Jennifer Check(Atrium Health Wake Forest Baptist), Charles R. Neal(University of Hawaiʻi at Mānoa), Julie A. Hofheimer(University of North Carolina at Chapel Hill)
Unknown
January 1, 2021
Cited by 0
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat
|The Journal of Comparative Neurology|1999|403
Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with125I-[14Tyr]-orphanin FQ binding
|The Journal of Comparative Neurology|1999|346
The Maternal Lifestyle Study: Drug Use by Meconium Toxicology and Maternal Self-Report
|PEDIATRICS|2001|307
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome
|Drug and Alcohol Dependence|2005|295